nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.144	0.253	CbGbCtD
Oxaprozin—PTGS2—Etoposide—peripheral nervous system neoplasm	0.142	0.249	CbGbCtD
Oxaprozin—PTGS1—Etoposide—peripheral nervous system neoplasm	0.12	0.21	CbGbCtD
Oxaprozin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.114	0.201	CbGbCtD
Oxaprozin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.049	0.0861	CbGbCtD
Oxaprozin—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000812	CcSEcCtD
Oxaprozin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000349	0.00081	CcSEcCtD
Oxaprozin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000349	0.00081	CcSEcCtD
Oxaprozin—Rash—Topotecan—peripheral nervous system neoplasm	0.000349	0.00081	CcSEcCtD
Oxaprozin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000349	0.000809	CcSEcCtD
Oxaprozin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000349	0.000809	CcSEcCtD
Oxaprozin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000347	0.000806	CcSEcCtD
Oxaprozin—Headache—Topotecan—peripheral nervous system neoplasm	0.000347	0.000805	CcSEcCtD
Oxaprozin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000346	0.000804	CcSEcCtD
Oxaprozin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000346	0.000804	CcSEcCtD
Oxaprozin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000346	0.000803	CcSEcCtD
Oxaprozin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000346	0.000803	CcSEcCtD
Oxaprozin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000346	0.000803	CcSEcCtD
Oxaprozin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000345	0.0008	CcSEcCtD
Oxaprozin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000345	0.0008	CcSEcCtD
Oxaprozin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000344	0.000798	CcSEcCtD
Oxaprozin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000344	0.000798	CcSEcCtD
Oxaprozin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000344	0.000798	CcSEcCtD
Oxaprozin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000343	0.000796	CcSEcCtD
Oxaprozin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000343	0.000796	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000796	CcSEcCtD
Oxaprozin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000343	0.000796	CcSEcCtD
Oxaprozin—Rash—Melphalan—peripheral nervous system neoplasm	0.000342	0.000793	CcSEcCtD
Oxaprozin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000341	0.000792	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.00079	CcSEcCtD
Oxaprozin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000785	CcSEcCtD
Oxaprozin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000338	0.000784	CcSEcCtD
Oxaprozin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000335	0.000777	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000774	CcSEcCtD
Oxaprozin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000331	0.000769	CcSEcCtD
Oxaprozin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.000767	CcSEcCtD
Oxaprozin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.000763	CcSEcCtD
Oxaprozin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.000763	CcSEcCtD
Oxaprozin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000329	0.000763	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000328	0.000761	CcSEcCtD
Oxaprozin—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000761	CcSEcCtD
Oxaprozin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000327	0.00076	CcSEcCtD
Oxaprozin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000326	0.000757	CcSEcCtD
Oxaprozin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000326	0.000757	CcSEcCtD
Oxaprozin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000325	0.000754	CcSEcCtD
Oxaprozin—Infection—Etoposide—peripheral nervous system neoplasm	0.000323	0.000749	CcSEcCtD
Oxaprozin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000322	0.000747	CcSEcCtD
Oxaprozin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000322	0.000747	CcSEcCtD
Oxaprozin—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000743	CcSEcCtD
Oxaprozin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000318	0.000739	CcSEcCtD
Oxaprozin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000318	0.000738	CcSEcCtD
Oxaprozin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000317	0.000736	CcSEcCtD
Oxaprozin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000736	CcSEcCtD
Oxaprozin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000317	0.000736	CcSEcCtD
Oxaprozin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000317	0.000736	CcSEcCtD
Oxaprozin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000316	0.000734	CcSEcCtD
Oxaprozin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000314	0.000729	CcSEcCtD
Oxaprozin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000729	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000727	CcSEcCtD
Oxaprozin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00031	0.000719	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000716	CcSEcCtD
Oxaprozin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000308	0.000715	CcSEcCtD
Oxaprozin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000307	0.000713	CcSEcCtD
Oxaprozin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000706	CcSEcCtD
Oxaprozin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000303	0.000704	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000704	CcSEcCtD
Oxaprozin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000695	CcSEcCtD
Oxaprozin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.000693	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000688	CcSEcCtD
Oxaprozin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.000683	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000681	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000678	CcSEcCtD
Oxaprozin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000292	0.000678	CcSEcCtD
Oxaprozin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000292	0.000677	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000674	CcSEcCtD
Oxaprozin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00029	0.000672	CcSEcCtD
Oxaprozin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000289	0.00067	CcSEcCtD
Oxaprozin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000289	0.00067	CcSEcCtD
Oxaprozin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000288	0.000668	CcSEcCtD
Oxaprozin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000666	CcSEcCtD
Oxaprozin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000663	CcSEcCtD
Oxaprozin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000285	0.000662	CcSEcCtD
Oxaprozin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.000661	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000657	CcSEcCtD
Oxaprozin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000283	0.000657	CcSEcCtD
Oxaprozin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000282	0.000655	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000653	CcSEcCtD
Oxaprozin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000651	CcSEcCtD
Oxaprozin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00028	0.000651	CcSEcCtD
Oxaprozin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000646	CcSEcCtD
Oxaprozin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000646	CcSEcCtD
Oxaprozin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000278	0.000645	CcSEcCtD
Oxaprozin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000644	CcSEcCtD
Oxaprozin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000643	CcSEcCtD
Oxaprozin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.000639	CcSEcCtD
Oxaprozin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000274	0.000637	CcSEcCtD
Oxaprozin—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000632	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000628	CcSEcCtD
Oxaprozin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000622	CcSEcCtD
Oxaprozin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000268	0.000621	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.00062	CcSEcCtD
Oxaprozin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000267	0.000619	CcSEcCtD
Oxaprozin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000618	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000617	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000266	0.000616	CcSEcCtD
Oxaprozin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000265	0.000615	CcSEcCtD
Oxaprozin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.000614	CcSEcCtD
Oxaprozin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000613	CcSEcCtD
Oxaprozin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.000609	CcSEcCtD
Oxaprozin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.000608	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000608	CcSEcCtD
Oxaprozin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.000605	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000603	CcSEcCtD
Oxaprozin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000258	0.000599	CcSEcCtD
Oxaprozin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000598	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000598	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000598	CcSEcCtD
Oxaprozin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000257	0.000596	CcSEcCtD
Oxaprozin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000257	0.000596	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000596	CcSEcCtD
Oxaprozin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000595	CcSEcCtD
Oxaprozin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000595	CcSEcCtD
Oxaprozin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000255	0.000592	CcSEcCtD
Oxaprozin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000254	0.00059	CcSEcCtD
Oxaprozin—Rash—Vincristine—peripheral nervous system neoplasm	0.000253	0.000587	CcSEcCtD
Oxaprozin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000253	0.000586	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000585	CcSEcCtD
Oxaprozin—Headache—Vincristine—peripheral nervous system neoplasm	0.000251	0.000583	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000575	CcSEcCtD
Oxaprozin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.000574	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000572	CcSEcCtD
Oxaprozin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000243	0.000563	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000562	CcSEcCtD
Oxaprozin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000555	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000553	CcSEcCtD
Oxaprozin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000238	0.000553	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.00055	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.00055	CcSEcCtD
Oxaprozin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000233	0.000541	CcSEcCtD
Oxaprozin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00023	0.000533	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000531	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000526	CcSEcCtD
Oxaprozin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000225	0.000523	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00052	CcSEcCtD
Oxaprozin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000224	0.000519	CcSEcCtD
Oxaprozin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000223	0.000518	CcSEcCtD
Oxaprozin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000222	0.000516	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000513	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00022	0.00051	CcSEcCtD
Oxaprozin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000508	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000507	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000503	CcSEcCtD
Oxaprozin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000215	0.000499	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000492	CcSEcCtD
Oxaprozin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000211	0.000489	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000488	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000486	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000207	0.00048	CcSEcCtD
Oxaprozin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000206	0.000479	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000479	CcSEcCtD
Oxaprozin—Rash—Etoposide—peripheral nervous system neoplasm	0.000205	0.000475	CcSEcCtD
Oxaprozin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000205	0.000475	CcSEcCtD
Oxaprozin—Headache—Etoposide—peripheral nervous system neoplasm	0.000203	0.000472	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000472	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00047	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000469	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000467	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000465	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000465	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000464	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000463	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000458	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000455	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000452	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000449	CcSEcCtD
Oxaprozin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000193	0.000448	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000447	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000445	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000443	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000439	CcSEcCtD
Oxaprozin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000436	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000432	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000431	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00043	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.00043	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000429	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000426	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000423	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000423	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000423	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000421	CcSEcCtD
Oxaprozin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000181	0.00042	CcSEcCtD
Oxaprozin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000416	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000415	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000414	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000414	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000412	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000409	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000406	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000403	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000403	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000399	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000395	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000394	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000391	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000391	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000388	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000385	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000383	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000382	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000382	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000379	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000378	CcSEcCtD
Oxaprozin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000377	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000376	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000373	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000372	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000367	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000365	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000361	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000354	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000351	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000349	CcSEcCtD
Oxaprozin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000348	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000348	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000346	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000344	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00034	CcSEcCtD
Oxaprozin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000336	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000334	CcSEcCtD
Oxaprozin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000334	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000334	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000322	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00032	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000311	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000309	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000309	CcSEcCtD
Oxaprozin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000303	CcSEcCtD
Oxaprozin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000299	CcSEcCtD
Oxaprozin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000289	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000281	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000279	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000277	CcSEcCtD
Oxaprozin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000269	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000268	CcSEcCtD
Oxaprozin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000266	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000266	CcSEcCtD
Oxaprozin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000265	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000259	CcSEcCtD
Oxaprozin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000251	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000249	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000247	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000246	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000245	CcSEcCtD
Oxaprozin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000232	CcSEcCtD
Oxaprozin—Propafenone—ABCB1—peripheral nervous system neoplasm	1.59e-05	0.326	CrCbGaD
Oxaprozin—Carbamazepine—ABCB1—peripheral nervous system neoplasm	1.22e-05	0.249	CrCbGaD
Oxaprozin—Phenytoin—ABCB1—peripheral nervous system neoplasm	1.18e-05	0.242	CrCbGaD
Oxaprozin—Methadone—ABCB1—peripheral nervous system neoplasm	8.93e-06	0.183	CrCbGaD
